Welcome Message

March - the month of NHMRC project grant submissions and the TSANZSRS18. We hope that all grants where submitted smoothly yesterday. Please take a moment to register for the conference!

We would like to highlight that this year we will be holding the inaugural Respiratory Research Excellence Awards which you are all invited to and encouraged to attend. Please join us and show your support and thanks to your colleagues, collaborators, and our sponsors. This session is in lieu of all ASM Awards sessions which have previously occurred over the duration of the conference, thus allowing more time in the program for research presentations, discussion and collaboration. Due to this change, SIG awards will be announced following the ASM by the TSANZ Central Office.

We wish you all the best in your preparation. See you in Adelaide.

Enjoy the March edition of your research roundup.

Prof Phil Hansbro

Prof Sandra Hodge

Co-Chairs, Research Sub-Committee

 

Open Awards

Vertex Cystic Fibrosis Research Awards

Lung Foundation Australia / A Menarini Pty Ltd 2018 Travel Awards

        

How to participate

Follow the links above to access each award application form and download the information sheet.

Please email the TSANZ Awards Coordinator with any questions, comments or enquires.

Watch this space for more award announcements...

Respirology Issue 23.3 - Editor’s Choice

Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma

Andreas S. Lappas, Anna S. Tzortzi, Efstathia M. Konstantinidi, Stephanie I. Teloniatis, Chara K. Tzavara, Sofia A. Gennimata, Nikolaos G. Koulouris, Panagiotis K. Behrakis

DOI: 10.1111/resp.13180

The Greek study team at the George D. Behrakis RESEARCH LAB in Athens. From left to right - seated: Panagiotis K Behrakis, Anna Tzortzi and Nikolaos G Koulouris ; standing: Chara K Tzavara, Stephanie I Teloniatis, Sofia A Gennimata, Efstathia Konstantinidi and Andreas Lappas.

 

Unfavourable outcome of glucocorticoid treatment in suspected idiopathic pulmonary fibrosis

Ivo A. Wiertz, Wim A. Wuyts, Coline H.M. van Moorsel, Adriane D.M. Vorselaars, Hendrik W. van Es,

Matthijs F.M. van Oosterhout, Jan C. Grutters

DOI: 10.1111/resp.13230

Unfavourable outcome of prednisone treatment in possible idiopathic pulmonary fibrosis patients

Medical Research Future Fund Grants

The Medical Research Future Fund (MRFF) is providing grants of financial assistance to support health and medical research and innovation, with the objective of improving the health and wellbeing of Australians.

The MRFF Low Survival Cancers and Diseases (LSCD) Grant Opportunity opened on  the 7th of March 2018 and will close at 5pm AEST on Wednesday 18 April 2018.

TSANZ is willing to partner with members on suitable (subject to review) MRFF projects, offering in-kind support by way of:

  • providing guidance in meeting the requirements of the grant
  • assistance in review of progress and data
  • promotion of the trial among members
  • meeting support for investigators
  • access to a conference call system (video or teleconference)
  • access to a venue for face to face meetings

Please contact hayley.see@thoracic.org.au to discuss partnership possibilities.

The Children's Hospital at Westmead: CF Research Funding

Funding is available for new or existing projects in paediatric Cystic Fibrosis to be conducted at the Children’s Hospital at Westmead. Application form Deadline: 23rd March, 2018 5pm AEDT.

For more information contact peter.cooper@health.nsw.gov.au

Research Project and Survey Requests

Explaining chronic breathlessness

Chronic breathlessness has been defined as ‘breathlessness that persists despite optimal treatment of underlying pathology and results in disability’ (Johnson et al. Eur Respir J 2017;49 (5)). This symptom is a common daily experience for people with a range of malignant and non-malignant respiratory, cardiovascular and neuromuscular conditions.

We know very little about how health professionals explain chronic breathlessness to people living with this symptom. This survey seek to collect information on the  explanations health professionals, from a variety of professional disciplines, use when explaining chronic breathlessness  to people living with this symptom (and their views on whether there is specific information which should  and should not be included in explanations). 

This electronic survey contains 13 questions and should take not more than 10 -12 minutes to complete. All responses will be confidential and anonymised by allocating an ID code to each participant. Details concerning the process including data management and privacy consideration are included in the Participant Information sheet included within the opening screens of the survey.

Ethical approval has been received from the Human Research Ethics Committee of the University of South Australia (ID: 200896)

For further information or to participate, please click here: 

Explain chronic breathlessness’   or copy and paste the following into your browser:

https://www.surveymonkey.com/r/Explain-Chronic-Breathlessness

For further information please contact Dr Marie Williams (E: marie.williams@unisa.edu.au or Ph: +61-8-8302 1153, University of South Australia) on behalf of the research team (Dr Kylie Johnston and Prof Dina Brooks)

 

‘Usual’ antenatal asthma management

Our research team at the Hunter Medical Research Institute (HMRI) and University of Newcastle is conducting a nationwide survey to determine what ‘usual’ antenatal asthma management consists of. Gaining this knowledge will help to form a foundation on which to build improved antenatal asthma management across Australia.

If you are a health professional who provides antenatal care within Australia then we invite you to participate in a survey. This survey should take approximately 10 minutes to complete.

Ethics approval has been granted for this study (NSW HREC Reference No: HREC/16/HNE/394).  All responses will be anonymous and confidential. Further information about the project and request for consent is outlined once you click on the survey link. If you have any questions regarding this research, please do not hesitate to contact Vanessa Murphy at Vanessa.Murphy@newcastle.edu.au or Karen McLaughlin on 0425277200.

Please click on the link below to proceed to the survey. If the link fails to load automatically, please cut and paste it into your internet browser:

https://redcap.hmri.org.au/surveys/?s=NR78PWYW49

Thank you,

Dr Vanessa Murphy, Vanessa.Murphy@newcastle.edu.au
Ms Karen McLaughlin, Karen.McLaughlin@hnehealth.nsw.gov.au

Australian Lung Cancer Conference

 

Register to hear the latest evidence-based information on the impact of immune-oncology, ALK, EGFR and ROS 1, staging of lung cancer, managing toxicity, stigma and survivorship and surgery.

The program features international speakers including:

  • A/Prof Marianne Davies, Acute Nurse Practitioner, Yale University School of Nursing
  • Dr Hisao Asamura, Thoracic Surgeon, Tokyo National Cancer Centre Hospital
  • Dr Jose Belderbos, Radiation Oncologist, Netherlands Cancer Institute
  • A/Prof Justin Gainor, Medical Oncologist, Massachusetts General Hospital
  • Prof Tony Mok, Medical Oncologist, Chinese University of Hong Kong
  • Prof Thomas Lynch, Medical Oncologist, Yale Cancer Centre.

Click here for the full program. Please note: this is currently being updated.

Industry Sponsored Symposiums

Seven Industry Sponsored Symposiums will be hosted as part of the ALCC including:

  • Pfizer evening symposium - Thursday 5 April
  • AstraZeneca morning symposium - Friday 6 April
  • Roche lunch symposium - Friday 6 April
  • BMS evening symposium - Friday 6 April
  • Slater and Gordon evening symposium - Friday 6 April
  • MSD morning symposium - Saturday 7 April
  • Roche-Foundation Medicine lunch symposium - Saturday 7 April

When registering be sure to select the industry sponsored symposium you would like to attend. If you would like to amend your registration to change or include these, please email Amelia Parsons via ameliap@lungfoundation.com.au

Australia New Zealand Lung Cancer Nurses Forum (ANZ-LCNF) Workshop

The workshop will be held on Thursday 5 April featuring international nurse speaker A/Prof Marianne Davies. Key topics include:

  • Importance of understanding biomarkers
  • Immunotherapy from the nurses perspective
  • Targeted therapies
  • Self-care for health care professionals
  • The latest in mesothelioma

Faculty of Radiation Oncology Lung Interest Cooperative (FROLIC) Workshop
Join the FROLIC committee for the first workshop at the Australian Lung Cancer Conference, featuring international radiation oncologist Dr Jose Beldebos. Topics include:

  • Thoracic radiotherapy for Stage I-III small cell lung cancer
  • Future directions for radiation therapy in Stage III non-small cell lung cancer
  • Future directions for SABR in Stage I non-small cell lung cancer

Click Here to Register Now